Cargando…

Specific antibody response of patients with common variable immunodeficiency to BNT162b2 coronavirus disease 2019 vaccination

Detalles Bibliográficos
Autores principales:	Abo-helo, Nizar, Muhammad, Emad, Ghaben-amara, Sondus, Panasoff, Josef, Cohen, Shai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325552/ https://www.ncbi.nlm.nih.gov/pubmed/34343675 http://dx.doi.org/10.1016/j.anai.2021.07.021

Ejemplares similares

Specific antibody response of 14 patients with common variable immunodeficiency to 3 BNT162b2 messenger RNA coronavirus disease 2019 vaccinations
por: Abo-Helo, Nizar, et al.
Publicado: (2022)

A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency
por: Mullur, Jyotsna, et al.
Publicado: (2021)

Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
por: Nishiguchi, Yamato, et al.
Publicado: (2021)

Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity( )
por: Morrocchi, Elena, et al.
Publicado: (2022)

BNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients
por: La Civita, Evelina, et al.
Publicado: (2023)

The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019
por: Fill, Lauren, et al.
Publicado: (2020)

Multisystem Inflammation and Organ Dysfunction After BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccination
por: Kahn, Benjamin, et al.
Publicado: (2021)

Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
por: Aljaberi, Rana, et al.
Publicado: (2020)

Antibody and T-cell responses to coronavirus disease 2019 vaccination in common variable immunodeficiency and specific antibody deficiency
por: Rosenthal, Jamie A., et al.
Publicado: (2023)

Specific Antibody and the T-Cell Response Elicited by BNT162b2 Boosting After Two ChAdOx1 nCoV-19 in Common Variable Immunodeficiency
por: Goda, Vera, et al.
Publicado: (2022)

Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors
por: Ballman, Madison, et al.
Publicado: (2021)

Incidence of Disease Flare After BNT162b2 Coronavirus Disease 2019 Vaccination in Patients With Rheumatoid Arthritis in Remission
por: Bixio, Riccardo, et al.
Publicado: (2021)

Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination
por: Kurashima, Kazuyoshi, et al.
Publicado: (2022)

IgG4-related disease: case report and literature review
por: Nizar, Abo-Helo, et al.
Publicado: (2015)

Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
por: Izumo, Takehiro, et al.
Publicado: (2021)

Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
por: Takada, Kazuki, et al.
Publicado: (2021)

Adverse Reactions after BNT162b2 Messenger RNA Vaccination for Coronavirus Disease 2019 in Healthcare Workers Compared with Influenza Vaccination
por: Kim, A-Sol, et al.
Publicado: (2023)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Common variable immunodeficiency - an update
por: Salzer, Ulrich, et al.
Publicado: (2012)

Comments on “Recurrent Aseptic Meningoencephalitis Following BNT162b2 Vaccination for COVID-19”
por: Finsterer, Josef
Publicado: (2023)

Impact of Previous Coronavirus Disease 2019 on Immune Response After a Single Dose of BNT162b2 Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine
por: Velasco, María, et al.
Publicado: (2021)

Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
por: Ammitzbøll, Christian, et al.
Publicado: (2021)

Association between Vaccination with the BNT162b2 mRNA Coronavirus Disease 2019 Vaccine and Noninfectious Uveitis: A Population-Based Study
por: Tomkins-Netzer, Oren, et al.
Publicado: (2022)

BNT162b2 coronavirus disease-2019 vaccination accelerated rheumatoid arthritis disease activity in chronic eosinophilic pneumonia: A case report
por: Morikawa, Moeko Murano, et al.
Publicado: (2022)

Acute cervical dystonia following the BNT162b2 mRNA COVID-19 vaccine
por: Algahtani, Hussein A., et al.
Publicado: (2022)

Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2
por: Bauernfeind, Stilla, et al.
Publicado: (2021)

The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data
por: Odnoletkova, Irina, et al.
Publicado: (2018)

Genetic defects in common variable immunodeficiency
por: Kopecký, O, et al.
Publicado: (2007)

Pathogenesis of autoimmunity in common variable immunodeficiency
por: Warnatz, Klaus, et al.
Publicado: (2012)

Autoimmune Cytopenias In Common Variable Immunodeficiency
por: Podjasek, Jenna C., et al.
Publicado: (2012)

Bronchiectasis caused by common variable immunodeficiency
por: Divino, Paulo Henrique do Amor, et al.
Publicado: (2015)

Common Variable Immunodeficiency and Circulating T(FH)
por: Coraglia, Ana, et al.
Publicado: (2016)

Renal Evaluation in Common Variable Immunodeficiency
por: Capistrano, Giovany Gomes, et al.
Publicado: (2018)

Common Variable Immunodeficiency and Gastric Malignancies
por: Leone, Patrizia, et al.
Publicado: (2018)

COVID-19 and Common Variable Immunodeficiency
por: Kaminski, Marina, et al.
Publicado: (2021)

Severe Ascites in Common Variable Immunodeficiency
por: Camões, Guilherme, et al.
Publicado: (2022)

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
por: Peeters, M., et al.
Publicado: (2021)

Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine
por: Shostak, Yael, et al.
Publicado: (2021)

One-year dynamics of antibody titers after three doses of SARS-CoV-2 BNT162b2 vaccine
por: Wand, Ori, et al.
Publicado: (2023)

Iodide Mumps
por: Panasoff, Josef, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6gai3o8q3bvpm39jeaagvstib1